Rigel Pharmaceuticals (RIGL) Soars 5.44% on 39% Revenue Surge

Rigel Pharmaceuticals (RIGL) shares surged by 5.44% today, marking a significant rebound after hitting its lowest level since December 2024, with an intraday decline of 5.31%.

Rigel Pharmaceuticals reported a 39% increase in revenue and achieved its first full year of net income. This financial performance is a significant milestone for the company, indicating strong growth and profitability. The company's expansion of its global footprint and development efforts are also contributing to its positive outlook. These factors are likely to have a significant impact on the stock price, driving investor confidence and interest in the company's future prospects.